Michael Lenardo, M.D. - Calico
Skip to content
0%
Calico
Research & Technology
Research & Technology
Publications
Drug Development
Drug Development
Patients
Partnering
Leadership
Careers
Job Openings
PostDoc Program
Mission and Values
Leadership
Research & Technology
Drug Development
Patients
Partnering
Collaborator Profiles
People
Publications
News & Media
Press Releases
Calico Stories
Life at Calico
Careers
Job Openings
PostDoc Program
Contact Us
Back to Leadership
Michael Lenardo, M.D.
Chief Scientific Officer
Mike is a distinguished physician-scientist and medical researcher who brings decades of experience to his role leading Calico’s research strategy.
About
Mike joined Calico in 2024 as Chief Scientific Officer, a role in which he is responsible for the company’s overall research strategy. He is establishing a lab that will address the aging process and associated diseases, expanding upon his work in human genetics.
Mike is widely recognized for his work on fundamental immunological mechanisms, including discovering the genetic basis, pathogenesis, and treatment of several congenital disorders of the immune system including Autoimmune Lymphoproliferative Syndrome, Caspase-8 deficiency syndrome, PASLI disease, XMEN disease, and CHAPLE disease.
Prior to joining Calico, Mike was Chief, Molecular Development of the Immune System Section, and Co-Director, National Institute of Allergy and Infectious Diseases Clinical Genomics Program at the National Institutes of Health.
Mike is a member of the U.S. National Academy of Sciences, the National Academy of Medicine and the American Academy of Arts and Sciences, and was designated an Officer of the Most Excellent Order of the British Empire (O.B.E), conferred by Queen Elizabeth II.
Mike earned his bachelor’s degree in Natural Sciences from Johns Hopkins University and his medical degree from Washington University in St. Louis. He completed his internship in internal medicine and research in biochemistry at the University of Iowa. He performed his postdoctoral training with Nobel laureates David Baltimore and Phillip Sharp at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology.
See Other Leadership Profiles
Cynthia Kenyon, Ph.D.
Vice President, Aging Research
Philip Kym, Ph.D.
Head of Drug Discovery
Jonathan W. Lewis, Ph.D.
Chief Business Officer
Jonathan Powell, M.D., Ph.D
Head of Development
PREVIOUS BIO    NEXT BIO
About Us
Research & Technology
Drug Development
Leadership
Partnering
Our Story
Life at Calico
Resources
Publications
Calico Stories
News & Media
Patients
Contact Us
Contact Us
Join Us
Follow Us
X
LinkedIn
Privacy Policy
Notice at Collection
Terms of Use
Code of Conduct
2026 Calico Life Sciences LLC. All rights reserved.
Close